BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11107924)

  • 1. [Fluorinated pyrimidines in oral treatment of advanced colorectal cancer].
    Todnem K; Harboe K; Zotova L; Lind A; Ogreid D
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2781-5. PubMed ID: 11107924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drugs in therapy of colorectal cancer: preclinical studies.
    Rustum YM; Cao S
    Semin Oncol; 1999 Dec; 26(6):612-20. PubMed ID: 10606254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral fluoropoyrimidines.
    Hoff PM; Royce M; Medgyesy D; Brito R; Pazdur R
    Semin Oncol; 1999 Dec; 26(6):640-6. PubMed ID: 10606257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [5-fluorouracil and dihydropyrimidine dehydrogenase].
    Kubota T
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):433-9. PubMed ID: 11329775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral fluoropyrimidines in colorectal cancer.
    Van Cutsem E; Peeters M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
    [No Abstract]   [Full Text] [Related]  

  • 7. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
    Cunningham D; Coleman R
    Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer.
    Van Cutsem E; Geboes K
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1089-108. PubMed ID: 18070705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical development of eniluracil: current status.
    Hohneker JA
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):52-6. PubMed ID: 9830627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral therapy for colorectal cancer: how to choose.
    Damjanov N; Meropol NJ
    Oncology (Williston Park); 2000 Jun; 14(6):799-807; discussion 807-8, 813-4,. PubMed ID: 10887632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluoropyrimidine treatment of colorectal cancer.
    Eng C; Kindler HL; Schilsky RL
    Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain].
    Croockewit AJ; de Boer JE; van Loenhout JW; Koopmans PP
    Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1117-20. PubMed ID: 12092301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery of oral anti-cancer fluoropyrimidine agents.
    Miura K; Shima H; Takebe N; Rhie J; Satoh K; Kakugawa Y; Satoh M; Kinouchi M; Yamamoto K; Hasegawa Y; Kawai M; Kanazawa K; Fujiya T; Unno M; Katakura R
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1355-1366. PubMed ID: 28379040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
    Papamichael D
    Oncologist; 1999; 4(6):478-87. PubMed ID: 10631692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation.
    Schilsky RL
    Clin Colorectal Cancer; 2002 May; 2(1):51-2. PubMed ID: 12453336
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic treatment of colorectal cancers--factual standards and perspectives].
    Miron L
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):752-8. PubMed ID: 14756014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral fluoropyrimidines in the treatment of colorectal cancer.
    Meropol NJ
    Eur J Cancer; 1998 Sep; 34(10):1509-13. PubMed ID: 9893621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
    Porschen R
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
    [No Abstract]   [Full Text] [Related]  

  • 20. The oral fluorouracil prodrugs.
    Pazdur R; Hoff PM; Medgyesy D; Royce M; Brito R
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):48-51. PubMed ID: 9830626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.